Alpine Woods Capital Investors’s Novo Nordisk NVO Stock Holding History

Alpine Woods Capital Investors’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-23,000	Closed	-$3.28M	–	181
2024 Q2	$3.28M	Sell	23,000 -12,000	-34%	-$1.59M	0.51%	67
2024 Q1	$4.49M	Buy	35,000 +200	+0.6%	+$23.8K	0.89%	38
2023 Q4	$3.6M	Buy	+34,800	New	+$3.44M	0.54%	58
2017 Q1	–	Sell	-240,000	Closed	-$4.3M	–	473
2016 Q4	$4.3M	Sell	240,000 -159,000	-40%	-$2.88M	0.24%	131
2016 Q3	$8.3M	Buy	+399,000	New	+$9.89M	0.46%	80

Other funds holding NVO

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Alpine Woods Capital Investors's NVO Position: Q3 2024 in Review

Alpine Woods Capital Investors sold out of Novo Nordisk (NVO) in Q3 2024, closing a stake of 23,000 shares — an estimated $3.28M sold.

Alpine Woods Capital Investors first reported a position in NVO in Q3 2016 and held it in 5 quarters. The position peaked at $8.3M in Q3 2016. 1,785 funds tracked by Wall St. Rank hold NVO as of Q3 2024.

Alpine Woods Capital Investors reported no remaining Novo Nordisk position as of Q3 2024 after selling out during the quarter.
Alpine Woods Capital Investors sold 23,000 Novo Nordisk shares in Q3 2024, an estimated $3.28M.
Alpine Woods Capital Investors first reported a position in Novo Nordisk in Q3 2016 and held it in 5 quarters.
Alpine Woods Capital Investors's Novo Nordisk position peaked at $8.3M in Q3 2016.
1,785 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2024.

Based on Alpine Woods Capital Investors's 13F filing for Q3 2024, filed 12 Nov 2024.